Allergy (and clinical immunology)
21.0K views | +6 today
Allergy (and clinical immunology)
Ressources et Actualités pour la spécialité Allergie
Your new post is loading...
Your new post is loading...
Suggested by Denise Neves Gameiro
May 13, 2016 1:26 PM
Scoop.it!

DBV: “These Additional Results Confirm our Potential of solving the Peanut Allergy problem Worldwide”

DBV: “These Additional Results Confirm our Potential of solving the Peanut Allergy problem Worldwide” | Allergy (and clinical immunology) | Scoop.it
The European Biotech News Website
No comment yet.
Scooped by Gilbert C FAURE
March 6, 2016 5:58 AM
Scoop.it!

Effect of Avoidance on Peanut Allergy after Early Peanut Consumption — NEJM

Effect of Avoidance on Peanut Allergy after Early Peanut Consumption — NEJM | Allergy (and clinical immunology) | Scoop.it
Original Article from The New England Journal of Medicine — Effect of Avoidance on Peanut Allergy after Early Peanut Consumption
No comment yet.
Scooped by Gilbert C FAURE
March 6, 2016 5:57 AM
Scoop.it!

Peanut allergy theory backed up by new research - BBC News

Peanut allergy theory backed up by new research - BBC News | Allergy (and clinical immunology) | Scoop.it
The long-lasting effects of eating peanut products as a baby to avoid the risk of allergy are supported by new research.
Gilbert C FAURE's insight:
NEJM 550 cases
No comment yet.
Scooped by Gilbert C FAURE
February 17, 2016 9:02 AM
Scoop.it!

How Low Should We Go - FullText - International Archives of Allergy and Immunology 2015, Vol. 168, No. 3 - Karger Publishers

Int Arch Allergy Immunol 2015;168:147-149

Gilbert C FAURE's insight:

Milk allergy is a common phenomenon with a prevalence of around 2% in 2-year-old children. Avoidance itself is not sufficient to prevent allergic reactions as suggested by one study reporting an incidence of 40% allergic reactions during a 12-month period. Thirty-seven percent of reactions were moderate to severe [1]. Therefore feasible treatment options for milk allergy are needed. Milk oral immunotherapy (OIT) has been investigated for treatment of milk allergy [2]. Many OIT trials targeted serving-size amounts of food such as approximately 5- 16 g in milk, 2 g in egg and 0.8-7 g in peanut OIT trials. Initial enthusiasm over OIT to milk was tempered by allergic reactions (19% with anaphylactic reaction at least once) and by limited long-term responders (31%) [3]........

No comment yet.
Scooped by Gilbert C FAURE
January 28, 2016 3:23 PM
Scoop.it!

Clinical and Translational Allergy | Full text | Incidence and risk factors for food hypersensitivity in UK infants: results from a birth cohort study

The prevalence of food hypersensitivity in the UK is still largely open to debate. Additionally its pathogenesis is also unclear although it is known that there are differing phenotypes.

Gilbert C FAURE's insight:
Results

Cumulative incidence of food hypersensitivity by 2 years of age was 5.0 %. The cumulative incidence for individual food allergens were hens’ egg 2.7 % (1.6–3.8); cows’ milk 2.4 % (1.4–3.5); peanut 0.7 % (0.1–1.3); soy 0.4 % (0.0–0.8); wheat 0.2 % (0.0–0.5) and 0.1 % (0.0–0.32) for fish. The cumulative incidence of IgE-mediated food allergy was 2.6 % with 2.1 % reacting to hens’ egg. For non-IgE-mediated food allergy the cumulative incidence was 2.4 % (cows’ milk 1.7 %). Predictors for any food hypersensitivity were wheeze, maternal atopy, increasing gestational age, age at first solid food introduction and mean healthy dietary pattern score. Predictors for IgE mediated allergy were eczema, rhinitis and healthy dietary pattern score whereas for non-IgE-mediated food allergy the predictors were dog in the home, healthy dietary pattern score, maternal consumption of probiotics during breastfeeding and age at first solid food introduction.

Conclusions

Just under half the infants with confirmed food hypersensitivity had no demonstrable IgE. In an exploratory analysis, risk factors for this phenotype of food hypersensitivity differed from those for IgE-mediated food allergy except for a healthy infant diet which was associated with less risk for both phenotypes.

OPEN

No comment yet.
Scooped by Gilbert C FAURE
January 20, 2016 9:13 AM
Scoop.it!

Detection of specific immunoglobulin E antibodies toward common airborne allergens, peanut, wheat, and latex in solvent/detergent-treated pooled pl... - PubMed - NCBI

Detection of specific immunoglobulin E antibodies toward common airborne allergens, peanut, wheat, and latex in solvent/detergent-treated pooled pl... - PubMed - NCBI | Allergy (and clinical immunology) | Scoop.it

Transfusion. 2016 Jan 18. doi: 10.1111/trf.13451. [Epub ahead of print]

No comment yet.
Scooped by Gilbert C FAURE
August 13, 2015 4:57 AM
Scoop.it!

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants - Annals of Allergy, Asthma & Immunology

Avoid #peanut_allergy by introducing #peanuts into an infants diet early, rather than later.. http://t.co/CUh84IMZN8
No comment yet.
Scooped by Gilbert C FAURE
June 24, 2015 12:18 PM
Scoop.it!

Peanut allergy drug slated for 2018 debut

Peanut allergy drug slated for 2018 debut | Allergy (and clinical immunology) | Scoop.it
A small French biopharmaceutical company has developed a new patch to help allergy sufferers increase their peanut tolerance.
No comment yet.
Scooped by Gilbert C FAURE
April 16, 2015 12:31 PM
Scoop.it!

A gut microbe that stops food allergies

A gut microbe that stops food allergies | Allergy (and clinical immunology) | Scoop.it
Giving mice common intestinal bacteria eliminated peanut allergies
No comment yet.
Scooped by Gilbert C FAURE
April 11, 2015 4:32 AM
Scoop.it!

Development of a Novel Strategy to Isolate Lipophilic Allergens (Oleosins) from Peanuts

Development of a Novel Strategy to Isolate Lipophilic Allergens (Oleosins) from Peanuts | Allergy (and clinical immunology) | Scoop.it
by Christian Schwager, Skadi Kull, Susanne Krause, Frauke Schocker, Arnd Petersen, Wolf-Meinhard Becker, Uta Jappe
Background Peanut allergy is one of the most severe class I food allergies with increasing prevalence.
No comment yet.
Scooped by Gilbert C FAURE
March 6, 2015 5:40 AM
Scoop.it!

NEJM — Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy

NEJM — Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy | Allergy (and clinical immunology) | Scoop.it
Original Article from The New England Journal of Medicine — Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
No comment yet.
Scooped by Gilbert C FAURE
March 2, 2015 9:28 AM
Scoop.it!

Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy — NEJM

Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy — NEJM | Allergy (and clinical immunology) | Scoop.it
Original Article from The New England Journal of Medicine — Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
No comment yet.
Scooped by Gilbert C FAURE
February 21, 2015 1:42 PM
Scoop.it!

Peanut allergies and emerging trends: Review of science and public policy - Journalist's Resource

Peanut allergies and emerging trends: Review of science and public policy - Journalist's Resource | Allergy (and clinical immunology) | Scoop.it
2015 review of recent research and relevant data that can help put peanut and food allergies in context, with a look at medical facts and trends relating to regulation.
No comment yet.
Scooped by Gilbert C FAURE
March 8, 2016 4:44 AM
Scoop.it!

Another LEAP Forward: Testing the Stability of Peanut Tolerance after Early Peanut Exposure - Now@NEJM

Another LEAP Forward: Testing the Stability of Peanut Tolerance after Early Peanut Exposure - Now@NEJM | Allergy (and clinical immunology) | Scoop.it
Over the past few decades, allergies have been on the rise worldwide, particularly in the United States.
No comment yet.
Scooped by Gilbert C FAURE
March 6, 2016 5:57 AM
Scoop.it!

Researchers at AAAAI Annual Meeting Show Eating Peanut in Early Years Reduces the Risk of Peanut Allergy, Even with Later Avoidance

Researchers at AAAAI Annual Meeting Show Eating Peanut in Early Years Reduces the Risk of Peanut Allergy, Even with Later Avoidance | Allergy (and clinical immunology) | Scoop.it
New England Journal of Medicine Peanut Study Makes Debut at AAAAI Annual Meeting
Gilbert C FAURE's insight:
bis by AAAAI
No comment yet.
Scooped by Gilbert C FAURE
February 23, 2016 9:55 AM
Scoop.it!

Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy - Full Text View - ClinicalTrials.gov

RT @FoodAllergy: “Patch” Clinical Trial for Peanut Allergy Now Recruiting https://t.co/t3NEtQ3qYN https://t.co/1GaKpYJkyK...

No comment yet.
Scooped by Gilbert C FAURE
February 15, 2016 9:06 AM
Scoop.it!

DBV Technologies | Viaskin® Peanut

DBV Technologies | Viaskin® Peanut | Allergy (and clinical immunology) | Scoop.it

Peanut allergy is one of the most common food allergies, and can cause severe, potentially fatal, allergic reactions, including anaphylaxis.

No comment yet.
Scooped by Gilbert C FAURE
January 24, 2016 3:56 AM
Scoop.it!

Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice - Gregory - 2015 - Plant Biotechnology Journal - Wiley Online Library

Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice - Gregory - 2015 - Plant Biotechnology Journal - Wiley Online Library | Allergy (and clinical immunology) | Scoop.it

Peanut allergy is an IgE-mediated adverse reaction to a subset of proteins found in peanuts. Immunotherapy aims to desensitize allergic patients through repeated and escalating exposures for several months to years using extracts or flours.

No comment yet.
Scooped by Gilbert C FAURE
January 8, 2016 11:17 AM
Scoop.it!

Practice Guidelines: Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants: Consensus Communication - American Family Physician

This consensus communication focuses on new data that support introducing peanuts early in infants, and it aims to assist with decisions about introduction; it can be used for guidance while formal guidelines are being developed.

No comment yet.
Scooped by Gilbert C FAURE
July 24, 2015 5:35 AM
Scoop.it!

US investors invest $281.5m in French allergy play - European Biotechnology News - European Biotechnology News

US investors invest $281.5m in French allergy play - European Biotechnology News - European Biotechnology News | Allergy (and clinical immunology) | Scoop.it
US money keeps flowing into Europe's biotechs. As the race for the peanut allergy market heats up, NASDAQ listed French biotech DBV has announced the successful closing of US$281m (€256m) share offering for its allergy products.
No comment yet.
Scooped by Gilbert C FAURE
June 16, 2015 2:51 PM
Scoop.it!

Results of New Peanut Allergy Trials Presented at EAACI Meeting

Results of New Peanut Allergy Trials Presented at EAACI Meeting | Allergy (and clinical immunology) | Scoop.it
The European Academy of Allergy and Clinical Immunology (EAACI) recently held its 2015 Annual Congress in Barcelona, Spain. FARE CEO Dr. James R. Baker, Jr. and FARE SVP of Research and Operations ...
No comment yet.
Scooped by Gilbert C FAURE
April 14, 2015 2:02 PM
Scoop.it!

FDA grants breakthrough designation for Viaskin Peanut in children

FDA grants breakthrough designation for Viaskin Peanut in children | Allergy (and clinical immunology) | Scoop.it
The FDA granted breakthrough therapy designation to Viaskin Peanut, an epicutaneous delivery system, for the treatment of children aged 6 to 11 years with peanut allergy, according to a manufacturer’s press release.The Viaskin Peanut (DBV Technologies)...
No comment yet.
Scooped by Gilbert C FAURE
April 10, 2015 3:45 PM
Scoop.it!

A Patch for Peanut Allergies

A Patch for Peanut Allergies | Allergy (and clinical immunology) | Scoop.it
French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial.
No comment yet.
Scooped by Gilbert C FAURE
March 4, 2015 2:12 PM
Scoop.it!

Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting | Allergy (and clinical immunology) | Scoop.it
From BioPortfolio: Epicutaneous Immunotherapy (EPIT) introduces new way to treat peanut allergies Houston, TX (PRWEB) February 22, 2015 A team of researchers unveiled the results ...
No comment yet.
Scooped by Gilbert C FAURE
February 28, 2015 12:11 PM
Scoop.it!

Peanut allergy 'cut by early exposure'

Peanut allergy 'cut by early exposure' | Allergy (and clinical immunology) | Scoop.it
Eating peanut products as a baby dramatically cuts the risk of allergy, a study suggests.
No comment yet.